Answers are grounded in this paper and cite their sources.
A new trinuclear ruthenium complex [RuIII3(TSA-H)2(TSA)4][NEt4] (1) with the non-toxic 2-thiosalicylic acid (TSA-H2) ligand could be prepared in a pure form and in a large quantity by a one-pot reaction. Complex 1 is stable under physiological conditions and forms adduct(s) with glutathione (GSH). It is anti-cancer active towards a panel of cancer cell lines, but does not exert its cytotoxicity through DNA binding. This is the first ruthenium complex reported to significantly attenuate the Wnt-β-catenin signaling in both transcriptomic and proteomic levels as demonstrated by DNA microarray, RT-PCR and Western blotting analyses.
No takes yet. Share an insight, caveat, or question.
Chan et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: